CRA_16847

CRA_16847 is a small molecule compound belonging to the class of organic compounds known as phenylbenzimidazoles. It has the chemical formula C18H13BrN4O5. The compound is primarily of interest in biochemistry and pharmacology due to its unique chemical structure and potential biological activity[1][2][3]. Literature suggests that it functions as an active site-directed serine protease inhibitor, indicating its mechanism involves inhibition of serine proteases, which are enzymes implicated in various physiological and pathological processes[4]. There is no evidence that CRA_16847 has been approved for clinical use or advanced into late-stage clinical trials.